Relatório global de análise do tamanho, quota e tendências do mercado global de gestão inteligente da diabetes – visão geral do setor e previsão para 2031

Análise de mercado de gestão inteligente da diabetes

O mercado inteligente de gestão da diabetes está a evoluir rapidamente, impulsionado pelos avanços na tecnologia e pela crescente ênfase nos cuidados de saúde personalizados. Este mercado abrange uma gama de dispositivos, incluindo medidores inteligentes de glicose, sistemas de monitorização contínua de glicose e soluções de administração de insulina que melhoram a gestão da diabetes. Com o aumento da prevalência da diabetes a nível mundial, a procura por soluções inovadoras que facilitem a monitorização em tempo real e a análise de dados está a aumentar. Os desenvolvimentos recentes, como as colaborações entre grandes empresas e o lançamento de novos produtos, como os monitores de glicose integrados em smartphones, estão a melhorar a experiência e a acessibilidade dos utilizadores. Além disso, a investigação e as parcerias em curso visam melhorar a adesão ao tratamento e os resultados dos doentes através de aplicações digitais de saúde. À medida que os sistemas de saúde mudam para os cuidados preventivos e a autogestão, o mercado da gestão inteligente da diabetes está preparado para um crescimento significativo, oferecendo oportunidades promissoras para as partes interessadas no ecossistema dos cuidados de saúde.

Tamanho do mercado de gestão inteligente da diabetes

O tamanho global do mercado inteligente de gestão da diabetes foi avaliado em 7,44 mil milhões de dólares em 2023 e deverá atingir os 22,76 mil milhões de dólares até 2031, com um CAGR de 15,00% durante o período de previsão de 2024 a 2031 . Além dos insights sobre cenários de mercado como como valor de mercado, taxa de crescimento, segmentação, cobertura geográfica e grandes players, os relatórios de mercado com curadoria da Data Bridge Market Research também incluem análise especializada aprofundada, epidemiologia de pacientes, análise de pipeline , análise de preços e enquadramento regulamentar.

Tendências de mercado de gestão inteligente da diabetes

“ Integração da Inteligência Artificial”

O mercado inteligente de gestão da diabetes está a testemunhar tendências transformadoras impulsionadas por inovações tecnológicas que melhoram os cuidados prestados aos doentes. Uma tendência proeminente é a integração da inteligência artificial (IA) e da aprendizagem automática nas ferramentas de gestão da diabetes. Estas tecnologias analisam grandes quantidades de dados de monitores de glicose e wearables, permitindo insights e recomendações personalizadas para os utilizadores. Inovações como as canetas inteligentes de insulina e os sistemas de circuito fechado também estão a ganhar força, permitindo a administração automatizada de insulina com base em leituras de glicose em tempo real. Esta tendência melhora a adesão ao tratamento e capacita os doentes para assumirem o controlo da sua saúde. Como resultado, o mercado está a evoluir para oferecer soluções mais fáceis de utilizar e eficazes, melhorando significativamente os resultados da gestão da diabetes.

Âmbito do relatório e segmentação do mercado de gestão inteligente da diabetes         

Smart Diabetes Management Market Definition

Smart diabetes management is the use of advanced technology and digital tools to monitor and manage diabetes effectively, encompassing devices and applications that enable real-time tracking of blood glucose levels, personalized insights, and enhanced communication between patients and healthcare providers.

Smart Diabetes Management Market Dynamics

Drivers

• Rising Prevalence of Diabetes

The rising prevalence of diabetes worldwide is significantly driving the demand for effective management solutions. With an estimated 537 million adults living with diabetes as of 2021, this number is projected to rise sharply in the coming years due to factors such as sedentary lifestyles, poor dietary habits, and genetic predispositions. As a result, there is a pressing need for innovative tools and technologies that can help individuals monitor and manage their condition effectively. Smart diabetes management solutions, such as continuous glucose monitors and insulin delivery systems, provide real-time data and personalized insights, empowering patients to take control of their health. This urgent demand for efficient management options is propelling growth in the smart diabetes management market, making it a critical area for investment and development.

• Consumer Demand for Personalization

The shift towards personalized healthcare is significantly influencing the development of tailored diabetes management solutions. As patients increasingly seek customized care that aligns with their individual health needs and lifestyles, healthcare providers are responding by adopting technologies that offer personalized insights and recommendations. Innovations such as smart glucose meters and mobile health applications allow for individualized monitoring and treatment adjustments based on real-time data. This trend enhances patient engagement and adherence and improves health outcomes by providing targeted interventions. Consequently, the demand for personalized diabetes management tools is driving growth in the smart diabetes management market.

Opportunities

• Integration of Wearable Technology

The proliferation of wearable devices presents significant opportunities for seamless integration with diabetes management solutions, fundamentally transforming how individuals monitor and manage their condition. These devices, including smartwatches and fitness trackers, can continuously collect vital health data such as blood glucose levels, physical activity, and heart rate. By integrating this data with diabetes management apps, users receive real-time feedback and personalized insights, empowering them to make informed decisions about their health. This continuous monitoring capability enhances patient engagement and facilitates proactive management, reducing the risk of complications. As consumer demand for wearable technology grows, the smart diabetes management market can leverage this trend to develop innovative solutions that improve patient outcomes and enhance the overall management experience.

• Advancement in Telehealth Services

The increasing acceptance of telehealth services is creating substantial opportunities for enhancing diabetes management through remote monitoring and consultations. This shift allows healthcare providers to connect with patients virtually, offering them the convenience of managing their condition from the comfort of their homes. For individuals living in remote or underserved areas, telehealth can significantly improve access to specialized care and diabetes management resources. Patients can benefit from real-time data sharing with healthcare professionals, enabling timely interventions and personalized care plans. Additionally, telehealth services often include educational resources and support systems that empower patients to take charge of their health. As telehealth continues to gain traction, the smart diabetes management market stands to capitalize on this trend by integrating remote monitoring solutions that improve patient outcomes and overall healthcare efficiency.

Restraints/Challenges

• High Costs of Investment

The high initial investment associated with advanced diabetes management technologies poses a significant challenge to widespread adoption among patients and healthcare providers. Many of these innovative solutions, such as continuous glucose monitoring systems and smart insulin pumps, come with substantial upfront costs that can deter potential users. For patients, especially those without adequate insurance coverage, the financial burden may limit access to essential management tools, impacting their ability to effectively control their condition. Healthcare providers, particularly smaller clinics and practices, may also find it difficult to allocate budget for these technologies, leading to disparities in care. Consequently, the prohibitive costs associated with adopting advanced diabetes management solutions can hinder their integration into everyday healthcare practices, ultimately affecting patient outcomes and overall market growth.

•  Limited Market Awareness

A significant lack of awareness regarding the benefits and functionalities of smart diabetes management technologies can impede their adoption among potential users. Many patients and healthcare providers may not fully understand how these innovative tools—such as continuous glucose monitors and mobile health applications—can enhance diabetes management and improve health outcomes. This gap in knowledge can lead to misconceptions or hesitance in adopting these technologies, as individuals may prefer traditional methods they are more familiar with. Additionally, without adequate education and outreach efforts from healthcare providers and manufacturers, patients may miss out on valuable opportunities for improved disease management. As a result, this lack of awareness can limit the overall growth and effectiveness of smart diabetes management solutions in the market.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Smart Diabetes Management Market Scope

The market is segmented on the basis of devices, device type, application, diabetes type, and end use. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Devices

• Smart Glucose Meters
• Continuous Glucose Monitoring Systems
• Smart Insulin Pens
• Smart Insulin Pumps
• Closed Loop Systems

Device Type

• Handheld Devices
• Wearable Devices

Application

• Diabetes and Blood Glucose Tracking Apps
• Obesity and Diet Management Apps

Diabetes Type

• Type 1 Diabetes
• Type 2 Diabetes

End Use

• Home Healthcare
• Hospitals
• Specialty Diabetes Clinics

 Smart Diabetes Management Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, devices, device type, application, diabetes type, and end use as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America leads the smart diabetes management market, primarily driven by the high prevalence of diabetes among its population. The region's favorable reimbursement policies further enhance access to advanced diabetes management technologies, making them more attainable for patients. Additionally, increased awareness and adoption of innovative solutions contribute to the robust growth of this market segment in North America.

The Asia-Pacific region is anticipated to experience the highest growth rate from 2024 to 2031, driven by the strategic focus of numerous established market players looking to expand their footprint in this dynamic market. This growing interest is fueled by the increasing prevalence of diabetes and the demand for advanced management solutions in the region. As companies invest in localized initiatives and innovative technologies, the Asia-Pacific market is poised for significant development and increased adoption of smart diabetes management solutions.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Smart Diabetes Management Market Share

O cenário competitivo do mercado fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença global, localizações e instalações de produção, capacidades de produção, pontos fortes e fracos da empresa , lançamento de produto, largura e amplitude do produto, aplicação domínio. Os dados acima fornecidos estão apenas relacionados com o foco das empresas em relação ao mercado.

Os líderes de mercado de gestão inteligente da diabetes que operam no mercado são:

• Abbott (EUA)
• PHC Holdings Corporation (Japão)
• Welldoc, Inc.
• Sanofi (França)
• (EUA)
• DarioHealth Corp.
• Medtronic (Irlanda)
• B. Braun SE (Alemanha)
• F. Hoffmann-La Roche Ltd (Suíça)
• Insulet Corporation (EUA)
• Ascensia Diabetes Care Holdings AG (Suíça)
• Tandem Diabetes Care, Inc.
• LifeScan IP Holdings, LLC (EUA)
• AgaMatrix (EUA)
• (EUA)

Últimos desenvolvimentos no mercado inteligente de gestão da diabetes

• Em abril de 2023, a Glooko, Inc., uma empresa líder de software, estabeleceu uma parceria global com a Hedia, empresa de desenvolvimento de algoritmos de dosagem de insulina. Esta colaboração visa criar uma solução interoperável que combine a monitorização remota de doentes, cuidados conectados e tecnologias terapêuticas digitais. Ao fazê-lo, procuram melhorar o acesso para indivíduos com diabetes tipo 1 e tipo 2 que necessitam de orientação sobre a dosagem de insulina em bólus.
• Em maio de 2023, a Medtronic plc, uma empresa líder global em tecnologia de saúde, anunciou acordos definitivos para adquirir a EOFlow Co. Ltd., conhecida pelos seus inovadores adesivos de insulina vestíveis. Esta aquisição visa melhorar as capacidades de administração automatizada de insulina e agilizar o tratamento da diabetes para os doentes. Ao incorporar a tecnologia EOFlow, a Medtronic procura reforçar a sua posição na indústria e, ao mesmo tempo, expandir a sua oferta de produtos para melhor servir os indivíduos que controlam a diabetes
• Em outubro de 2021, a Roche estabeleceu uma parceria com o Grupo Zur Rose para melhorar o apoio aos indivíduos com diabetes e aos seus prestadores de cuidados na gestão da medicação diária. Esta colaboração visa integrar as soluções da Roche Diabetes Care com as dos principais fornecedores externos, criando um ecossistema de saúde mais abrangente. Ao conectar os seus produtos de saúde inovadores, a Roche e o Grupo Zur Rose procuram melhorar a qualidade de vida geral das pessoas que vivem com diabetes

SKU-52324